301 related articles for article (PubMed ID: 35076466)
1. Supramolecular Nanostructures for Vaccines.
Carmona-Ribeiro AM
Biomimetics (Basel); 2021 Dec; 7(1):. PubMed ID: 35076466
[TBL] [Abstract][Full Text] [Related]
2. Nanovaccines: A game changing approach in the fight against infectious diseases.
Priyanka ; Abusalah MAH; Chopra H; Sharma A; Mustafa SA; Choudhary OP; Sharma M; Dhawan M; Khosla R; Loshali A; Sundriyal A; Saini J
Biomed Pharmacother; 2023 Nov; 167():115597. PubMed ID: 37783148
[TBL] [Abstract][Full Text] [Related]
3. Cationic Nanostructures for Vaccines Design.
Carmona-Ribeiro AM; Pérez-Betancourt Y
Biomimetics (Basel); 2020 Jul; 5(3):. PubMed ID: 32645946
[TBL] [Abstract][Full Text] [Related]
4. Stability of luciferase plasmid entrapped in cationic bilayer vesicles.
Manosroi A; Thathang K; Werner RG; Schubert R; Manosroi J
Int J Pharm; 2008 May; 356(1-2):291-9. PubMed ID: 18281170
[TBL] [Abstract][Full Text] [Related]
5. Cationic Nanostructures as Adjuvants for Vaccines.
Carmona-Ribeiro AM; Mathiazzi BI; Pérez-Betancourt Y
Methods Mol Biol; 2022; 2412():233-245. PubMed ID: 34918247
[TBL] [Abstract][Full Text] [Related]
6. Tailoring inorganic nanoadjuvants towards next-generation vaccines.
Li X; Wang X; Ito A
Chem Soc Rev; 2018 Jul; 47(13):4954-4980. PubMed ID: 29911725
[TBL] [Abstract][Full Text] [Related]
7. Polymeric nanostructure vaccines: applications and challenges.
Simón-Vázquez R; Peleteiro M; González-Fernández Á
Expert Opin Drug Deliv; 2020 Jul; 17(7):1007-1023. PubMed ID: 32476491
[TBL] [Abstract][Full Text] [Related]
8. Cationic and Biocompatible Polymer/Lipid Nanoparticles as Immunoadjuvants.
Pérez-Betancourt Y; Araujo PM; Távora BCLF; Pereira DR; Faquim-Mauro EL; Carmona-Ribeiro AM
Pharmaceutics; 2021 Nov; 13(11):. PubMed ID: 34834275
[TBL] [Abstract][Full Text] [Related]
9. Nanoadjuvants Produced by Advanced Nanochelating Technology in the Inactivated-Severe Acute Respiratory Syndrome Coronavirus-2 Vaccine Formulation: Preliminary Results on Cytokines and IgG Responses.
Kalanaky S; Fakharzadeh S; Karimi P; Hafizi M; Jamaati H; Hassanzadeh SM; Khorasani A; Mahdavi M; Nazaran MH
Viral Immunol; 2023; 36(6):409-423. PubMed ID: 37506342
[TBL] [Abstract][Full Text] [Related]
10. Potential of Cationic Liposomes as Adjuvants/Delivery Systems for Tuberculosis Subunit Vaccines.
Khademi F; Taheri RA; Momtazi-Borojeni AA; Farnoosh G; Johnston TP; Sahebkar A
Rev Physiol Biochem Pharmacol; 2018; 175():47-69. PubMed ID: 29700609
[TBL] [Abstract][Full Text] [Related]
11. Nanovaccines for Advancing Long-Lasting Immunity against Infectious Diseases.
Gao X; Wang X; Li S; Saif Ur Rahman M; Xu S; Liu Y
ACS Nano; 2023 Dec; 17(24):24514-24538. PubMed ID: 38055649
[TBL] [Abstract][Full Text] [Related]
12. Plasmid-DNA lipid and polymeric nanovaccines: a new strategic in vaccines development.
Tejeda-Mansir A; García-Rendón A; Guerrero-Germán P
Biotechnol Genet Eng Rev; 2019 Apr; 35(1):46-68. PubMed ID: 30587085
[TBL] [Abstract][Full Text] [Related]
13. Nanovaccines and their mode of action.
Zaman M; Good MF; Toth I
Methods; 2013 May; 60(3):226-31. PubMed ID: 23623821
[TBL] [Abstract][Full Text] [Related]
14. Advancements in prophylactic and therapeutic nanovaccines.
Bhardwaj P; Bhatia E; Sharma S; Ahamad N; Banerjee R
Acta Biomater; 2020 May; 108():1-21. PubMed ID: 32268235
[TBL] [Abstract][Full Text] [Related]
15. Carrier-free subunit nanovaccine amplifies immune responses against tumors and viral infections.
Chen H; Li Y; Li L; Yang Z; Wen Z; Liu L; Liu H; Chen Y
Acta Biomater; 2023 Mar; 158():525-534. PubMed ID: 36572250
[TBL] [Abstract][Full Text] [Related]
16. Recent progress in application of nanovaccines for enhancing mucosal immune responses.
Du G; Qin M; Sun X
Acta Pharm Sin B; 2023 Jun; 13(6):2334-2345. PubMed ID: 37425056
[TBL] [Abstract][Full Text] [Related]
17. Small cationic DDA:TDB liposomes as protein vaccine adjuvants obviate the need for TLR agonists in inducing cellular and humoral responses.
Milicic A; Kaur R; Reyes-Sandoval A; Tang CK; Honeycutt J; Perrie Y; Hill AV
PLoS One; 2012; 7(3):e34255. PubMed ID: 22470545
[TBL] [Abstract][Full Text] [Related]
18. Polymeric nanoparticle vaccines to combat emerging and pandemic threats.
Wibowo D; Jorritsma SHT; Gonzaga ZJ; Evert B; Chen S; Rehm BHA
Biomaterials; 2021 Jan; 268():120597. PubMed ID: 33360074
[TBL] [Abstract][Full Text] [Related]
19. Self-adjuvanting cancer nanovaccines.
Liao Z; Huang J; Lo PC; Lovell JF; Jin H; Yang K
J Nanobiotechnology; 2022 Jul; 20(1):345. PubMed ID: 35883176
[TBL] [Abstract][Full Text] [Related]
20. Safety and biocompatibility of injectable vaccine adjuvants composed of thermogelling block copolymer gels.
Adams JR; Senapati S; Haughney SL; Wannemuehler MJ; Narasimhan B; Mallapragada SK
J Biomed Mater Res A; 2019 Aug; 107(8):1754-1762. PubMed ID: 30972906
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
